The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder
The DOI matches its Crossref record; 335 of the 335 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Although clinically highly relevant, the recognition and treatment of bipolar mixed states has played only an underpart in recent guidelines. This WFSBP guideline has been developed to supply a systematic overview of all scientific evidence pertaining to the acute and long-term treatment of bipolar mixed states in adults. METHODS: Material used for these guidelines is based on a systematic literature search using various data bases. Their scientific rigour was categorised into six levels of evidence (A-F), and different grades of recommendation to ensure practicability were assigned. We examined data pertaining to the acute treatment of manic and depressive symptoms in bipolar mixed patients, as well as data pertaining to the prevention of mixed recurrences after an index episode of any type, or recurrence of any type after a mixed index episode. RESULTS: Manic symptoms in bipolar mixed states appeared responsive to treatment with several atypical antipsychotics, the best evidence resting with olanzapine. For depressive symptoms, addition of ziprasidone to treatment as usual may be beneficial; however, the evidence base is much more limited than for the treatment of manic symptoms. Besides olanzapine and quetiapine, valproate and lithium should also be considered for recurrence prevention. LIMITATIONS: The concept of mixed states changed over time, and recently became much more comprehensive with the release of DSM-5. As a consequence, studies in bipolar mixed patients targeted slightly different bipolar subpopulations. In addition, trial designs in acute and maintenance treatment also advanced in recent years in response to regulatory demands. CONCLUSIONS: Current treatment recommendations are still based on limited evidence, and there is a clear demand for confirmative studies adopting the DSM-5 specifier with mixed features concept.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is also congruent with current recommendations for augmentation in patients with unipolar TRD by the World Federation of Societies of Biological Psychiatry Task Force which considers lithium as first-line agent and aripiprazole and quetiapine as alternatives (Grunze et al., 2018).”
From Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis (2022) · cites this paper as Grunze et al., 2018
Citations
Cites
Items 201–335 of 335
Tural, Ü., & Önder, E. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02042.x · Cited by 57 · cited 1×
“Finally, typical antipsychotics put patients on greater risk of a malignant neuroleptic syndrome than atypical antipsychotics (Tural and Onder 2010).”
BackgroundThe prevalence of mixed episodes during the course of illness in bipolar disorder
Kessing, L. V. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01131.x · Cited by 56 · cited 1×
“Notably, it is likely that the prevalence of mixed episodes increases during the course of bipolar illness, and especially so among women (Kessing 2008).”
BackgroundIs there an excess of significant findings in published studies of psychotherapy for depression?
Flint, J., Cuijpers, P., Horder, J., Koole, S. L., & Munafò, M. R. (2015) · Psychological Medicine · doi:10.1017/s0033291714001421 · Cited by 56 · cited 2×
“The task force is aware of several inherent limitations of these guidelines: namely publication bias (Turner et al. 2008; Flint et al. 2015), sponsor bias (Lundh et al.”
BackgroundStabilization in the treatment of mania, depression and mixed states
Kupfer, D. J., Frank, E., Grochocinski, V. J., Luther, J. F., Houck, P. R., Swartz, H. A., & Mailinger, A. G. (2000) · Acta Neuropsychiatrica · doi:10.1017/s0924270800035547 · Cited by 56 · cited 2×
“2010), a longer duration of illness after the first hospitalisation (Cassidy and Carroll 2001), and are more difficult to treat (Kupfer et al. 2000).”
BackgroundWoo, Y. S., Shim, I. H., Wang, H.-R., Song, H. R., Jun, T., & Bahk, W. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.034 · Cited by 55 · cited 1×
“The meaningfulness of this, however, remains highly controversial, since it can be implied that depressive episodes with mixed features are a part of the bipolar spectrum (Woo et al. 2015; Weibel and Bertschy 2016) as further discussed here below.”
BackgroundBowden, C. L., Collins, M. A., McElroy, S. L., Calabrese, J. R., Swann, A. C., Weisler, R. H., & Wozniak, P. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300788 · Cited by 55 · cited 3×
“Based on a post hoc analysis of the maintenance study by Bowden et al. (2000) valproate was considered more effective than lithium as a prophylactic agent after a mixed index episode (Bowden et al. 2005), although neither medication separated from placebo.”
BackgroundMethodSelf-citationCalabrese, J. R., Pikalov, A., Streicher, C., Cucchiaro, J., Mao, Y., & Loebel, A. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.06.013 · Cited by 55
Expanding the group of bipolar disorders
Marneros, A. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00349-9 · Cited by 54 · cited 2×
“As with the previous guidelines, we did not include schizoaffective disorders per se despite their wide similarities with bipolar disorder (Marneros 2001b) as it was felt that such a broad spectrum view would go beyond the scope of this paper.”
BackgroundResultTeratogenesis associated with antibipolar agents
Nguyen, H. T., Sharma, V., & McIntyre, R. S. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0011-z · Cited by 54 · cited 4×
“(Nguyen et al. 2009).”
BackgroundInfluentialDissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder
Baldessarini, R. J., Salvatore, P., Khalsa, H.-M. K., & Tohen, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.014 · Cited by 54 · cited 1×
“In firstepisode bipolar disorder, more than two-thirds of episodes show a mixture of manic and depressive symptoms, which, however, may not always fulfil threshold criteria for a mixed specifier (Baldessarini et al. 2010; Vieta et al. 2014).”
BackgroundSponsors’ participation in conduct and reporting of industry trials: a descriptive study
Lundh, A., Krogsbøll, L. T., & Gøtzsche, P. C. (2012) · Trials · doi:10.1186/1745-6215-13-146 · Cited by 54 · cited 2×
“2015), sponsor bias (Lundh et al. 2012) and, finally, the limitations of evidence itself.”
BackgroundInoue, T., Inagaki, Y., Kimura, T., & Shirakawa, O. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.023 · Cited by 53 · cited 3×
“2009) and other studies (Benazzi et al. 2004; Inoue et al. 2015) demonstrated that mixed symptoms, as well as 6 H.”
BackgroundResultSokolski, K. N., Green, C., Maris, D. E., & DeMet, E. M. (1999) · Annals of Clinical Psychiatry · doi:10.1023/a:1022361412956 · Cited by 53 · cited 1×
“Another study enrolled 10 mixed bipolar patients who improved quickly in both manic (P< 0.01) and depressive (P< 0.05) symptoms when GBP was added (Sokolski et al. 1999).”
BackgroundInfluentialFornaro, M., Stubbs, B., De Berardis, D., Perna, G., Valchera, A., Veronese, N., Solmi, M., & Ganança, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020241 · Cited by 53 · cited 2×
“For this reason, the task force also feels that the inclusion of this post hoc analysis in the metaanalysis by Fornaro et al. (2016) entitled ‘Atypical antipsychotics in the treatment of acute bipolar depression with mixed features: a systematic review and exploratory meta-analysis of…”
BackgroundAkiskal, H. S., & Benazzi, F. (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029919 · Cited by 52
Azorin, J., Sapin, C., & Weiller, E. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.013 · Cited by 51 · cited 3×
“The Azorin et al. (2013) paper states that ‘These post hoc efficacy and safety analyses were based on the ITT dataset, which comprised all randomised patients who took at least one dose of study medication and had at least one valid post-baseline YMRS assessment‘, the ANCOVA of the YMRS and MADRS…”
MethodInfluentialSelf-citationZorrilla, I., Aguado, J., Haro, J. M., Barbeito, S., López Zurbano, S., Ortiz, A., López, P., & Gonzalez-Pinto, A. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12366 · Cited by 51 · cited 1×
“Nevertheless, quitting cannabis improves functionality in patients with a previous mixed manic episode (Zorrilla et al. 2015).”
BackgroundTohen, M. F., Sutton, V. K., Calabrese, J. R., Sachs, G. S., & Bowden, C. L. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.003 · Cited by 50 · cited 2×
“001) than did placebo-treated patients (Tohen et al. 2009).”
ResultInfluentialSelf-citationCariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy
Citrome, L. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0004-9 · Cited by 50 · cited 3×
“The reported figures for akathisia range from 4.8% (for 1.5mg in bipolar depression) to approximately 25% with dosages up to 12mg in the acute mania studies (Citrome 2013; Durgam et al. 2016; Earley et al. 2017).”
BackgroundInfluentialBrown, E. S., Davila, D., Nakamura, A., Carmody, T. J., Rush, A. J., Lo, A., Holmes, T., Adinoff, B., Caetano, R., Swann, A. C., et al. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12445 · Cited by 50 · cited 1×
“In the secondary outcomes, a non-significant greater reduction in the self-rated Inventory of Depressive Symptoms (IDS-SR) was observed with quetiapine; however, a separate analysis for mixed patients is not reported (Brown et al. 2014).”
ResultSuperiority of Lithium Over Verapamil in Mania: A Randomized, Controlled, Single-Blind Trial
Walton, S. A., Berk, M., & Brook, S. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1108 · Cited by 50 · cited 1×
“In addition, it needs to be noted that verapamil was equally efficacious as lithium in one double-blind study in acute mania (Pal Singh 2008), but inferior to lithium in another single-blind, head-tohead study (Walton et al. 1996).”
BackgroundKessing, L. V., Hellmund, G., & Andersen, P. K. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111414091 · Cited by 48 · cited 1×
“Kessing, Hellmund, and Andersen (2011) compared rates of switch to, or addition of, another psychotropic, and rates of psychiatric hospitalisation for patients treated with lamotrigine or lithium in clinical practice.”
BackgroundMallakh, R. S. E., Vieta, E., Rollin, L., Marcus, R. N., Carson, W. H., & McQuade, R. D. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.003 · Cited by 48
Self-citationMeta-analysis: Fact or fiction? How to interpret meta-analyses
Huf, W., Kalcher, K., Pail, G., Friedrich, M.-E., Filzmoser, P., & Kasper, S. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.551544 · Cited by 48 · cited 1×
“Those meta-analyses that we consulted, if the evidence remained unclear based on single studies, were selected according to the quality criteria defined by Huf et al. (2011).”
MethodSelf-citationLevy, R. (1970) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.3.414 · Cited by 48 · cited 1×
“According to the DSM-IV, mixed states imply that diagnostic criteria for a manic episode and a depressive episode (except for the duration criterion) are fulfilled concurrently, following the restrictive concept as originally proposed by Winokur et al. (1969).”
BackgroundLee, H.-J., Son, G.-H., & Geum, D. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.3.225 · Cited by 48 · cited 2×
“Based on the circadian rhythm hypotheses of mixed features, where mixed features express a state of transitional unstable circadian rhythm (Lee et al. 2013), the use of antidepressants affecting circadian rhythmicity may be advantageous.”
BackgroundCutler, A. J., Datto, C. J., Nordenhem, A., Minkwitz, M. C., Acevedo, L. D., & Darko, D. F. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.10.002 · Cited by 48 · cited 1×
“For mixed patients (134 out of 316) as a subgroup, quetiapine was not better than placebo for improving of manic or depressive symptoms (Cutler et al. 2011).”
BackgroundEfficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features
Tohen, M. F., Kanba, S., McIntyre, R. S., Fujikoshi, S., & Katagiri, H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.003 · Cited by 48
Muralidharan, K., Ali, M., Silveira, L. E., Bond, D. J., Fountoulakis, K. N., Lam, R. W., & Yatham, L. N. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.032 · Cited by 47 · cited 2×
“In the opinion of the task force, this also makes the result for asenapine in the meta-analysis of Muralidharan et al. (2013) questionable, as the evidence for asenapine is only based on the publication by Azorin et al. (2013), and, in addition, questions the validity of the whole meta-analysis…”
BackgroundResultSelf-citationPrevalence of mixed mania using 3 definitions
Vieta, E., & Morralla, C. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.019 · Cited by 47 · cited 1×
“A major problem for including mixed states in studies is the lack of a generally accepted definition (Gonz alez-Pinto et al. 2003; Cassidy et al. 2008; Vieta and Morralla 2010; Swann et al. 2013).”
BackgroundSelf-citationZiprasidone and the Corrected QT Interval
Camm, A. J., Karayal, O. N., Meltzer, H. Y., Kolluri, S., O’Gorman, C., Miceli, J. J., Tensfeldt, T. G., & Kane, J. M. (2012) · CNS Drugs · doi:10.2165/11599010-000000000-00000 · Cited by 46 · cited 1×
“Although ziprasidone can prolong the QTc interval, this has not resulted in increases in sudden death or cardiac sudden death (Camm et al. 2012).”
BackgroundClinical Experience Using Adjunctive Gabapentin in Treatment-Resistant Bipolar Mixed States
Perugi, G., Toni, C., Ruffolo, G., Sartini, S., Simonini, E., & Akiskal, H. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979219 · Cited by 46 · cited 1×
“…mixed episode, found that 50% of them were responders (CGI 1 or 2 points), and that while there was no significant reduction of manic symptoms, depressive symptoms were greatly reduced (P¼ 0.0001), a reduction positively correlated with mixed residual symptomatology (P¼ 0.003) (Perugi et al. 1999).”
BackgroundInfluentialMixed state discrimination: A DSM problem that won׳t go away?
Malhi, G. S., Lampe, L. A., Coulston, C. M., Tanious, M., Bargh, D. M., Curran, G., Kuiper, S., Morgan, H., & Fritz, K. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.01.008 · Cited by 46 · cited 1×
“Of note, neither distractibility nor psychomotor agitation define a major depressive episode with mixed features (Malhi et al. 2014; Perugi et al. 2015).”
BackgroundAdjunctive gabapentin treatment of bipolar disorder
Vieta, E., Martinez-Arán, A., Nieto, E., Colom, F., Reinares, M., Benabarre, A., & Gastó, C. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00514-9 · Cited by 46 · cited 1×
“Finally, another open-label study which enrolled BD-I or -II patients with subsyndromal features (YMRS> 6 or HAM-D> 12, and CGI-B>3) found again that, while mania scores did not substantially improve, depression was significantly improved (P< 0.002) (Vieta et al. 2000).”
BackgroundInfluentialSelf-citationMedda, P., Toni, C., Mariani, M. G., De Simone, L., Mauri, M., & Perugi, G. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09181 · Cited by 46 · cited 2×
“The largest case series with mixed patients comes from Medda et al. (2015), who performed an analysis using data obtained from 197 of 203 consecutive patients with a bipolar mixed state, according to DSMIV-TR diagnostic criteria, who were treated with ECT between January 2006 and May 2011.”
MethodPetri, E., Bacci, O., Barbuti, M., Pacchiarotti, I., Azorin, J., Angst, J., Bowden, C. L., Mosolov, S., Vieta, E., Young, A. H., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12519 · Cited by 46
Self-citationIn-patient care costs of patients with bipolar I disorder: A comparison between two European centers
González-Pinto, A. M., Dardennes, R. M., de Zélicourt, M., López, P., Oliveros, R. G., Vieta, E., Barbeito, S., Echevarría, E. M., & Fagnani, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.05.010 · Cited by 45
Self-citationYatham, L. N., Fountoulakis, K. Ν., Rahman, Z. U., Ammerman, D., Fyans, P., Marler, S. V., Baker, R. A., & Carlson, B. X. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.042 · Cited by 45 · cited 1×
“Yatham et al. (2013) conducted a post hoc analysis of a 52-week maintenance combination study (aripiprazoleþ lithium or valproate versus placeboþ lithium or valproate), in 107 patients with DSM-IV mixed mania at entry but stabilised at baseline (ClinicalTrials.gov Identifier: NCT00261443, original…”
MethodSelf-citationBrieger, P., Röttig, S., Ehrt, U., Wenzel, A., Blöink, R., & Marneros, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00331-2 · Cited by 45 · cited 1×
“In line with Akiskal’s theory, Brieger et al. (2003) examined the temperament of bipolar patients with and without a history of mixed episodes with the TEMPS-A scale and found some evidence that manic mixed episodes occur more often in patients with an inverse, depressive and anxious temperament.”
ResultMixed depression: a clinical marker of bipolar-II disorder
Benazzi, F. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.010 · Cited by 43 · cited 1×
“It has been hypothesised that this new diagnostic designation is a precursor of bipolar disorder and that patients meeting these criteria should be treated as such (Benazzi 2005; Benazzi 2006).”
BackgroundPreti, A., Vrublevska, J., Veroniki, A. A., Huedo-Medina, T. B., & Fountoulakis, K. N. (2016) · Evidence Based Mental Health · doi:10.1136/eb-2016-102412 · Cited by 43 · cited 1×
“…crucial: A systematic MEDLINE search for a recent meta-analysis of the prevalence of generalised anxiety disorder in BD returned 1300 results but identified only seven out of 30 eligible articles, whereas the rest were identified by hand search in reviews, text books etc. (Preti et al. 2016).”
BackgroundVerdolini, N., Perugi, G., Samalin, L., Murru, A., Angst, J., Azorin, J., Bowden, C. L., Mosolov, S. N., Young, A. H., Barbuti, M., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12777 · Cited by 43 · cited 4×
“2001), more irritability (Swann 2000), aggressiveness (Verdolini et al. 2017), suicidality (Dilsaver et al.”
BackgroundInfluentialSelf-citationAsenapine review, part II: clinical efficacy, safety and tolerability
Citrome, L. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.908183 · Cited by 42 · cited 1×
“Asenapine' s effects on weight and metabolic variables appear modest, as are its effects on the QTc interval and on prolactin (Citrome 2014).”
BackgroundTreatment of Bipolar I Rapid Cycling Patients During Dysphoric Mania with Olanzapine
González-Pinto, A. M., Tohen, M. F., Lalaguna, B., Pérez-Heredia, J., Fernández-Corres, B., Gutiérrez, M., & Micó, J. A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00002 · Cited by 42
Verapamil treatment for women with bipolar disorder
Wisner, K. L., Peindl, K. S., Perel, J. M., Hanusa, B. H., Piontek, C. M., & Baab, S. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01338-5 · Cited by 41 · cited 1×
“Seventy-seven percent of the woman (seven out of nine) with mixed states fulfilled response criteria on the mania scale, and two responded on the depression scales as well (Wisner et al. 2002).”
BackgroundThe safety and tolerability of atypical antipsychotics in bipolar disorder
Seemüller, F., Forsthoff, A., Dittmann, S., Born, C., Bernhard, B., Severus, W. E., & Grunze, H. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.5.849 · Cited by 39 · cited 2×
“The safety and tolerability profile of risperidone has been described in great detail in previous articles of this series (Grunze et al. 2009; Grunze et al. 2013) and in key review papers (Seem€uller et al. 2005).”
BackgroundSelf-citationPerugi, G., Angst, J., Azorin, J., Bowden, C. L., Caciagli, A., Mosolov, S. N., Vieta, E., Young, A. H., & the BRIDGE‐II‐Mix Study Group (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12457 · Cited by 39 · cited 1×
“It has also been noted that a mixed manic feature specifier may easily be attributed to patients with depression and comorbid borderline personality disorder, where agitated dysphoria is a common phenotype (Perugi et al. 2016; de la Rosa et al. 2017).”
BackgroundSelf-citationMedda, P., Mauri, M., Fratta, S., Ciaponi, B., Miniati, M., Toni, C., Dell’Osso, L., & Perugi, G. (2013) · Journal of Ect · doi:10.1097/yct.0b013e3182887b7a · Cited by 39 · cited 1×
“Medda et al. (2013) published a prospective naturalistic study that followed 36 bipolar patients with a medication-resistant severe depression or mixed state index episode that responded to acute ECT (mean duration¼ 55.3 ± SD, 30.4 weeks).”
BackgroundInfluentialWoo, Y. S., Bahk, W., Chung, M. Y., Kim, D., Yoon, B., Lee, J. H., Ahn, Y. M., Chung, S., Kim, J., Lee, K. H., et al. (2011) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1240 · Cited by 38 · cited 1×
“Another smaller maintenance study comparing aripiprazoleþ valproate versus placeboþ valproate after a manic or mixed index episode included only a very small number of mixed patients, and separate outcomes have not been reported (Woo et al. 2011).”
ResultEfficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies
Stahl, S. M., Lombardo, I., Loebel, A. D., & Mandel, F. S. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.023 · Cited by 38
Are manic symptoms that ‘dip’ into depression the essence of mixed features?
Malhi, G. S., Fritz, K., Allwang, C., Burston, N., Cocks, C., Devlin, J., Harper, M., Hoadley, B., Kearney, B. G., Klug, P., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.009 · Cited by 38 · cited 1×
“…of this (Goldberg et al. 2009) and other studies (Benazzi et al. 2004; Inoue et al. 2015) demonstrated that mixed symptoms, as well as distractibility, irritability and psychomotor agitation (which have been omitted from the DSM-5 mixed features specifier) indicate bipolarity (Malhi et al. 2016).”
ResultEarley, W. R., Durgam, S., Lu, K., Debelle, M., Laszlovszky, I., Vieta, E., & Yatham, L. N. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.032 · Cited by 38 · cited 2×
“The reported figures for akathisia range from 4.8% (for 1.5mg in bipolar depression) to approximately 25% with dosages up to 12mg in the acute mania studies (Citrome 2013; Durgam et al. 2016; Earley et al. 2017).”
BackgroundInfluentialSelf-citationVieta, E., Suppes, T., Ekholm, B., Udd, M., & Gustafsson, U. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.014 · Cited by 37 · cited 1×
“Furthermore, a post hoc analysis of the mixed patients included in these two previous RCTs confirmed these results, and further described that both manic and depressive symptoms improved with quetiapine combination (P¼ 0.004 and P¼ 0.011, respectively) (Vieta et al. 2012).”
ResultInfluentialSelf-citationFindling, R. L., & Ginsberg, L. D. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s68951 · Cited by 36 · cited 1×
“Findling and Ginsberg (2014) conducted a 26-week open study of extended-release carbamazepine in 157 children and adolescents suffering from a DSM-IV manic or mixed episode.”
BackgroundBacklund, L., Ehnvall, A., Hetta, J. E., Isacsson, G., & Ågren, H. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2008.12.009 · Cited by 35 · cited 2×
“A retrospective study found that the presence of three symptoms of the opposite polarity was a predictor of poor long-term outcome in lithium-treated mixed patients (Backlund et al. 2009).”
BackgroundKatagiri, H., Takita, Y., Tohen, M. F., Higuchi, T., Kanba, S., & Takahashi, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.045 · Cited by 35 · cited 1×
“A third post hoc analysis also including a Japanese study (Katagiri et al. 2012), looking at a total of 125 patients with mania with DSM-5 mixed depressive features specifier.”
MethodDimensions of mania: differences between mixed and pure episodes
González-Pinto, A., Aldama, A., González Pinto, A., Mosquera, F., de Heredia, J. L. P., Ballesteros, J., & Gutiérrez, M. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.04.019 · Cited by 35
A prospective study of inter-episode consistency of manic and mixed subtypes of bipolar disorder
Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00446-3 · Cited by 35 · cited 2×
“Several reports suggested a higher rate of comorbid substance abuse in mixed patients (Tohen et al. 1998; Goldberg et al. 1999; Tundo et al. 2015; McIntyre, Soczynska, et al. 2015); however, this could not be verified in all studies (Cassidy et al. 2001b).”
BackgroundDilsaver, S. C., & Swann, A. C. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00194-8 · Cited by 34 · cited 1×
“The use of antidepressants in bipolar disorder has also been associated with the de novo induction of mixed states (Dilsaver and Swann 1995; El-Mallakh et al. 2008).”
BackgroundMcIntyre, R. S., McElroy, S. L., Eudicone, J. M., Forbes, R. A., Carlson, B. X., & Baker, R. A. (2011) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.11m01182 · Cited by 34 · cited 1×
“Mean laboratory values were within the normal or borderline range for both treatment groups across all BMI categories (McIntyre et al. 2011).”
BackgroundClinical subtypes of severe bipolar mixed states
Perugi, G., Medda, P., Reis, J., Rizzato, S., Mariani, M. G., & Mauri, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.08.037 · Cited by 34 · cited 2×
“Of note, the distinct subtypes of mixed states as described by Kraepelin may still hold true and have therapeutic implications, as shown by Perugi et al. (2013) in their cluster analysis of clinical subtypes of severe bipolar mixed states.”
BackgroundMethodAdjunctive Topiramate in Hospitalized Children and Adolescents with Bipolar Disorders
Barzman, D. H., DelBello, M. P., Kowatch, R. A., Warner, J., Rofey, D. L., Stanford, K. E., Rappaport, K., Daniels, J. P., & Strakowski, S. M. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.931 · Cited by 34 · cited 1×
“A retrospective study in adolescents evaluated adjunctive topiramate, and found that 59% of patients with mixed mania (10 out of 17) responded to treatment (CGI-I 2) (Barzman et al. 2005).”
BackgroundBerk, M., Tiller, J. W. G., Zhao, J., Yatham, L. N., Malhi, G. S., & Weiller, E. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08827 · Cited by 34 · cited 5×
“Although the combined post hoc analysis by Szegedi et al. (2013) and Berk et al. (2015), are conducted in reasonably large samples, it is not apparent whether they have been planned a priori as part of the investigational plan and study protocols.”
BackgroundInfluentialSelf-citationNeurobiologic Dimensions of Depression and Mania
Carroll, B. J. (1983) · Springer eBooks · doi:10.1007/978-3-642-69129-4_11 · Cited by 32 · cited 1×
“Similarly, Carroll (1983) proposed a ‘NeoKraepelinian’ model of bipolar mixed episodes, where the three key dimensions are hedonic function, central pain regulation and psychomotor regulation.”
MethodTreatment of bipolar mixed state with olanzapine.
Sharma, V., & Pistor, L. (1999) · PubMed · Cited by 32
Rapid Efficacy of Olanzapine Augmentation in Nonpsychotic Bipolar Mixed States
Ketter, T. A., Winsberg, M. E., DeGolia, S. G., Dunai, M., Tate, D. L., & Strong, C. M. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0207e · Cited by 32 · cited 2×
“The first evidence for adjunctive olanzapine treatment came from a case report of two mixed bipolar patients who achieved complete remission of symptoms after the addition of olanzapine to mood stabilisers (Ketter et al. 1998).”
BackgroundSuppes, T. M., Ketter, T. A., Gwizdowski, I. S., Dennehy, E. B., Hill, S. J., Fischer, E. G., Snow, D. E., Gonzalez, R., Sureddi, S., Shivakumar, G., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.031 · Cited by 32 · cited 2×
“Finally, there is an RCT in hypomanic patients with mixed features (BD-II (DSM-IV-TR) with YMRS scores 12 and MADRS scores 15), which found that adjunctive quetiapine was superior to adjunctive placebo in improving overall severity as measured with the CGI-BP and depressive symptoms, but not (hypo)manic symptoms (Supp…”
BackgroundMethodTargum, S. D., Suppes, T. M., Pendergrass, J. C., Lee, S. H., Silva, R., Cucchiaro, J. B., & Loebel, A. D. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.007 · Cited by 32 · cited 1×
“At this time, controlled evidence for treatment is virtually restricted to lurasidone (Suppes, Silva, et al. 2016; Targum et al. 2016).”
BackgroundKanba, S., Kawasaki, H., Ishigooka, J., Sakamoto, K., Kinoshita, T., & Kuroki, T. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.669047 · Cited by 31 · cited 1×
“Another acute RCT, the AMAZE study, conducted in an Asian population, included only 28DSM-IV mixed patients, a sample too small to allow for a separate meaningful analysis (Kanba et al. 2014).”
BackgroundClothier, J., Swann, A. C., & Freeman, T. P. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199202001-00003 · Cited by 31 · cited 1×
“The concept of dysphoric mania as suggested by Clothier et al. (1992) is not well-defined, but sometimes used in the context of drug trials to refer to mania with some depressed features which are either not pronounced enough or too short to fulfil the criteria for a major depressive episode.”
BackgroundTakeshima, M., & Oka, T. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.077 · Cited by 30 · cited 1×
“An antidepressant-induced ‘activation syndrome’ is about four times more frequent in bipolar II and bipolar NOS patients than in unipolar major depression (52% vs 14%, respectively) (Takeshima and Oka 2013).”
BackgroundElectroconvulsive Therapy in Aarhus, Denmark, in 1984: Its Application in Nondepressive Disorders.
Strömgren, L. S. (1988) · PubMed · Cited by 30
Long-Term Worsening of Bipolar Disorder Related with Frequency of Antidepressant Exposure
Strejilevich, S. A., Martino, D. J., Marengo, E., Igoa, A., Fassi, G., Whitham, E. A., & Ghaemi, S. N. (2011) · Annals of Clinical Psychiatry · doi:10.1177/104012371102300305 · Cited by 29 · cited 1×
“Current evidence from prospective or retrospective studies support the notion that mixed patients are at higher risk for a maniform switch (Bottlender et al. 2004; Strejilevich et al. 2011; Valenti et al. 2011; Inoue et al. 2015; Barbuti et al. 2017).”
BackgroundPikalov, A., Tsai, J., Mao, Y., Silva, R., Cucchiaro, J. B., & Loebel, A. D. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0075-7 · Cited by 29 · cited 2×
“…the controlled acute treatment trials were also eligible for a 6-month open-label extension study (Ketter et al. 2016), which was then prolonged for an additional 18 months of continuation treatment with flexible, once-daily doses of lurasidone in the range of 20–80mg (Pikalov et al. 2017).”
BackgroundEfficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5
Tohen, M. F., McIntyre, R. S., Kanba, S., Fujikoshi, S., & Katagiri, H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.039 · Cited by 28
Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder
Young, A., & Eberhard, J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82532 · Cited by 27 · cited 2×
“Estimates suggest that about one-third of all manic episodes meet the criteria for a DSM-5 manic episode with mixed features (Vieta et al. 2014; Young and Eberhard 2015; Reinares et al. 2015).”
BackgroundInfluentialA Clinician’s Guide to Monitoring Kidney Function in Lithium-Treated Patients
Jefferson, J. W. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05917yel · Cited by 27 · cited 1×
“Long-term lithium treatment affects kidney function (Tredget et al. 2010; Kessing et al. 2015), and close monitoring of the eGRF is essential part of lithium safety measures (Jefferson 2010).”
BackgroundCycloid Psychoses Revisited: Case Reports, Literature Review, and Commentary
Salvatore, P., Bhuvaneswar, C. G., Ebert, D. H., Maggini, C., & Baldessarini, R. J. (2008) · Harvard Review of Psychiatry · doi:10.1080/10673220802167899 · Cited by 27 · cited 1×
“Besides calling for their recognition for clinical and research purposes, based on their heuristic value (Salvatore et al. 2008) these guidelines will not address them because of a lack of validation and specific therapeutic studies.”
BackgroundDrug safety evaluation of ziprasidone
Citrome, L. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.560114 · Cited by 27 · cited 1×
“The safety and tolerability profile of ziprasidone appears favourable (Citrome 2011).”
BackgroundJames, A. C., Wotton, C. J., Duffy, A. C., Hoang, U., & Goldacre, M. J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.018 · Cited by 27 · cited 2×
“…been well acknowledged for long time and is logically evident, that theoretically all ‘unipolar’ (more precisely ‘nonbipolar’) episodes of major depression could be part of bipolar disorder due to the well-known and not uncommon unipolar-bipolar conversion (Tondo et al. 2014; James et al. 2015).”
BackgroundMaking sense of DSM-5 mania with depressive features
Reinares, M., del Mar Bonnín, C., Hidalgo-Mazzei, D., Undurraga, J., Mur, M., Nieto, E., Sáez, C., & Vieta, E. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415585583 · Cited by 27 · cited 1×
“Estimates suggest that about one-third of all manic episodes meet the criteria for a DSM-5 manic episode with mixed features (Vieta et al. 2014; Young and Eberhard 2015; Reinares et al. 2015).”
BackgroundSelf-citationClinical Correlates of Response to Valproate in Geriatric Inpatients
Niedermier, J. A., & Nasrallah, H. A. (1998) · Annals of Clinical Psychiatry · doi:10.3109/10401239809147033 · Cited by 27
Tundo, A., Musetti, L., Benedetti, A., Berti, B., Massimetti, G., & Dell’Osso, L. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.07.018 · Cited by 26 · cited 5×
“Patients with mixed mania have higher rates of recurrence (Hantouche et al. 2006; Tundo et al. 2015), psychiatric re-admissions (Perugi et al.”
BackgroundMethodInfluentialTreating mixed mania/hypomania: a review and synthesis of the evidence
Takeshima, M. (2016) · CNS Spectrums · doi:10.1017/s1092852916000845 · Cited by 26 · cited 1×
“Overall, it may be speculated that, similarly to rapid cycling, combination therapy could be more efficacious than monotherapy for the treatment of mixed states, and may be preferable at least in severe cases (Takeshima 2017).”
BackgroundValproic acid for dysphoric mania in a mentally retarded adolescent.
Mc, W., Sa, W., Vb, G., & Nj, R. (1995) · PubMed · Cited by 25
Clinical correlates of response to valproate in geriatric inpatients.
Niedermier, J. A., & Nasrallah, H. A. (1998) · Annals of Clinical Psychiatry · doi:10.1023/a:1022394012821 · Cited by 25 · cited 1×
“A open study by Niedermier and Nasrallah (1998) is suggestive of efficacy of valproate in this patient group.”
BackgroundTardito, D., Tiraboschi, E., Kasahara, J., Racagni, G., & Popoli, M. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007140 · Cited by 25
Bipolar Patients' Quality of Life in Mixed States: A Preliminary Qualitative Study
Mortensen, G. L., Vinberg, M., Mortensen, S. L., Jørgensen, M. B., & Eberhard, J. (2015) · Psychopathology · doi:10.1159/000381479 · Cited by 25 · cited 1×
“As the result of a small interview series, Mortensen et al. (2015) noted that participants described mixed states as worse than other bipolar disorder states but their residual symptoms as prolonged.”
Background150e anniversaire de la Folie Circulaire
Pichot, P. (2004) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33801-4 · Cited by 24 · cited 1×
“In 1854, the French psychiatrist Falret described ‘transitional states’ that emerged during the switch from mania to depression and depression to mania (Falret 1854; Sedler 1983; Pichot 2004).”
BackgroundLong-Term Safety and Efficacy of Ziprasidone in Subpopulations of Patients With Bipolar Mania
Keck, P. E., Versiani, M., Warrington, L. E., Loebel, A. D., & Horne, R. L. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04045 · Cited by 23
Long‐term inter‐episode stability of syndromes underlying mania
Sato, T., Bottlender, R., Sievas, M., Schröter, A., Hecht, S., & Möller, H. ‐. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00194.x · Cited by 23 · cited 1×
“This syndromal stability was not substantially affected by gender, age of onset or intermittent substance abuse (Sato et al. 2003).”
BackgroundSelf-citationVieta, E. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12624 · Cited by 23
Self-citationAffective dimensions as a diagnostic tool for bipolar disorder in first psychotic episodes
Arrasate, M., González–Ortega, I., Alberich, S., Gutiérrez, M., Martínez‐Cengotitabengoa, M., Mosquera, F., Cruz, N., Torres, M. Á. G., Henry, C., & González-Pinto, A. M. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.07.005 · Cited by 22 · cited 1×
“In addition, the presence of a depressive dimension and the absence of activation has been found to be linked with misdiagnosis in those BD inpatients with a first psychotic episode (Arrasate et al. 2014).”
BackgroundZeeuws, D., Rycker, K. D., Raedt, R. D., Beyne, M. D., Baeken, C., & Vanderbruggen, N. (2010) · Brain stimulation · doi:10.1016/j.brs.2010.03.001 · Cited by 22 · cited 1×
“The same outcome, improvement in depressive but not manic symptoms, was reported in an additional cases of one mixed episode in a patient not responding to ECT (Zeeuws et al. 2010b; Zeeuws et al. 2011).”
BackgroundEfficacy of Electroconvulsive Therapy in Bipolar Disorder with Mixed Features
Palma, M., Ferreira, B., Borja-Santos, N., Trancas, B., Monteiro, C., & Cardoso, G. (2016) · Depression Research and Treatment · doi:10.1155/2016/8306071 · Cited by 20 · cited 2×
“…et al. 1992) and Akiskal's criteria (MDE plus two to three manic/hypomanic symptoms), which may be considered as a DSM-5 mixed specifier proxy, Palma et al. (2016) analysed ECT data from a total of 50 ECT course treatments that were performed in 41 bipolar patients in the Department of…”
BackgroundMethodInfluentialde la Rosa, I., Oquendo, M. A., García, G., Stanley, B., González-Pinto, A. M., Liu, S.-M., & Blanco, C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11190 · Cited by 20 · cited 1×
“It has also been noted that a mixed manic feature specifier may easily be attributed to patients with depression and comorbid borderline personality disorder, where agitated dysphoria is a common phenotype (Perugi et al. 2016; de la Rosa et al. 2017).”
BackgroundKemp, D. E., Karayal, O. N., Calabrese, J. R., Sachs, G. S., Pappadopulos, E. A., Ice, K. S., SIU, C. O., & Vieta, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.06.005 · Cited by 19 · cited 1×
“Of note is the negligible impact on metabolic parameters, prolactin and the fact that ziprasidone is relatively weight neutral (Kemp et al. 2012).”
BackgroundSelf-citationLenzi, A., Marazziti, D., Raffaelli, S., & Cassano, G. B. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00033-r · Cited by 18 · cited 1×
“The two mixed patients in the study achieved a partial, but not a full resolution of symptoms (Lenzi et al. 1995).”
BackgroundDannlowski, U., Baune, B. T., Böckermann, I., Domschke, K., Evers, S., Arolt, V., Hetzel, G., & Rothermundt, M. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.963 · Cited by 18 · cited 1×
“A 6-week open-label study compared adjunctive quetiapine to venlafaxine in 21 patients experiencing acute agitated major depression to patients only taking venlafaxine as an antidepressant (Dannlowski et al. 2008).”
BackgroundGrande, I., Hidalgo‐Mazzei, D., Nieto, E., Mur, M., Sáez, C., Forcada, I., & Vieta, E. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.003 · Cited by 18 · cited 1×
“Probably as a result of those post hoc analyses, clinicians tend to use adjunctive asenapine in patients with less severe manic symptoms but more complex clinical profile, including more mixed episodes in the past as shown by a recent survey (Grande et al. 2015).”
BackgroundSelf-citationEfficacy and tolerability of asenapine for acute mania in bipolar I disorder
Vita, A., Peri, L. M. D., Siracusano, A., & Sacchetti, E. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836290d2 · Cited by 17 · cited 1×
“The safety and tolerability profile of asenapine in short- and long-term treatment is generally considered as reasonably good, and especially better than, e.g., olanzapine with respect to metabolic issues (Vita et al. 2013).”
BackgroundDepression, mania, and feeling bad: the role of dysphoria in mixed states
Swann, A. C. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020405.x · Cited by 17 · cited 1×
“…more past mixed episodes (Wilhelm et al. 2007), higher probability of mixed episodes at illness onset (Perugi et al. 2001), more irritability (Swann 2000), aggressiveness (Verdolini et al. 2017), suicidality (Dilsaver et al. 1994; Strakowski et al. 1996; Balazs et al. 2006; Rihmer and D€ome…”
BackgroundOlanzapine for mixed episodes of bipolar disorder
ZULLINO, D. F., & Baumann, P. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300214 · Cited by 17
Major Mood Disorders and Suicidal Behavior
Rihmer, Z., & Döme, P. (2016) · Wiley eBooks · doi:10.1002/9781118903223.ch4 · Cited by 17 · cited 3×
“…monotherapy might worsen the cross-sectional picture of bipolar depression and unipolar depression with bipolar features specifier by aggravating the pre-existing mixed state or by inducing de novo mixed features which, in turn, can increase the risk of suicidal behaviour (Rihmer and D€ome 2016).”
BackgroundWu, H. E., & Okusaga, O. O. (2014) · Psychiatric Quarterly · doi:10.1007/s11126-014-9319-1 · Cited by 16 · cited 1×
“This is particularly true if a prophylactic treatment might increase the risk of provoking a mixed state, e.g., long-term antidepressant continuation after a depressive index episode (El-Mallakh et al. 2008), or antipsychotic-induced dysphoria after a manic index episode (Wu and Okusaga 2015).”
BackgroundCost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes
Sawyer, L., Azorin, J., Chang, S., Rinciog, C., Guiraud-Diawara, A., Marre, C., & Hansen, K. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.914030 · Cited by 15 · cited 1×
“These findings were also confirmed by another health-economic study using a Markov-model and looking also at mixed patients (Sawyer et al. 2014).”
ResultSelf-citationGhaemi, S. N. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00557.x · Cited by 15 · cited 1×
“The first scholarly systematic descriptions of mixed states by Kraepelin and Weygandt date back to 1899 (Kraepelin 1899; Weygandt 1899); since then their operationalisation, and even their acceptance, have been a matter of controversy (Ghaemi 2008).”
BackgroundRethinking the classification of mixed affective episodes in ICD-11
Østergaard, S. D., Rothschild, A. J., Bertelsen, A., & Mors, O. N. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.012 · Cited by 14
A double-blind comparative study of clinical efficacy of verapamil versus lithium in acute mania
Singh, G. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500802209670 · Cited by 14 · cited 1×
“In addition, it needs to be noted that verapamil was equally efficacious as lithium in one double-blind study in acute mania (Pal Singh 2008), but inferior to lithium in another single-blind, head-tohead study (Walton et al. 1996).”
BackgroundSzegedi, A., Zhao, J., & McIntyre, R. S. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.024 · Cited by 14 · cited 2×
“…a further post hoc analysis of the two pivotal acute studies (McIntyre et al. 2009; McIntyre et al. 2010a) combined two criteria of the analysis of Szegedi et al. (2013) and examined a subgroup of patients (n¼ 98) meeting criteria both for DSM-IV-TR criteria for mixed episodes and a baseline…”
BackgroundYoung, A. H. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2316 · Cited by 14 · cited 4×
“In addition, it used comparators with unproven efficacy in mixed states: Gabapentin and lamotrigine, and numbers were small in each arm (Mokhber et al. 2008).”
BackgroundMethodInfluentialDépression mixte et DSM-5 : mise au point critique
Weibel, S., & Bertschy, G. (2015) · L Encéphale · doi:10.1016/j.encep.2015.08.006 · Cited by 14 · cited 1×
“The meaningfulness of this, however, remains highly controversial, since it can be implied that depressive episodes with mixed features are a part of the bipolar spectrum (Woo et al. 2015; Weibel and Bertschy 2016) as further discussed here below.”
BackgroundDiagnostic reliability in schizoaffective disorder
Murru, A., Manchia, M., Tusconi, M., Carpiniello, B., Pacchiarotti, I., Colom, F., & Vieta, E. (2016) · Bipolar Disorders · doi:10.1111/bdi.12366 · Cited by 14 · cited 2×
“2011), and in clinical practice, a clear delineation of a psychotic mixed bipolar episode from a schizoaffective disorder with mixed features is often difficult and does not have therapeutic consequences (Murru et al. 2016).”
BackgroundSelf-citationCatapano-Friedman, L. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750284144 · Cited by 14
Rihmer, Z., Döme, P., & Gonda, X. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318299d2d5 · Cited by 13 · cited 1×
“…major depressive disorder patients have clinically significant, intradepressive current or lifetime subthreshold (hypo)manic symptoms (‘unipolar depression with mixed features’), these patients could be considered and should be treated as mixed bipolar depressive patients (Rihmer et al. 2013).”
BackgroundCaresano, C., Sciascio, G. D., Fagiolini, A. M., Maina, G., Perugi, G., Ripellino, C., & Vampini, C. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0139-3 · Cited by 13 · cited 1×
“Considering long-term treatment, a pharmacoeconomic model was developed to simulate the management of Italian BD-I patients with mixed episodes over a 5-year time horizon by combining clinical parameters with resource utilisation (Caresano et al. 2014).”
MethodTreatment of Mixed Mania with Risperidone and Mood Stabilizers
Benabarre, A., Vieta, E., Colom, F., Martinez, A., Reinares, M., & Corbella, B. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600925 · Cited by 13 · cited 1×
“Improvements in HAM-D were significant from week 1 onward (P¼ 0.0001) and remained significant until 6-months endpoint (P< 0.0001) (Benabarre et al. 2001).”
BackgroundInfluentialSelf-citationMixed Depression, Suicidality, and Antidepressants
Benazzi, F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1024b · Cited by 12 · cited 1×
“It has been hypothesised that this new diagnostic designation is a precursor of bipolar disorder and that patients meeting these criteria should be treated as such (Benazzi 2005; Benazzi 2006).”
BackgroundClinical decision making in the treatment of mixed states
Grunze, H., & Azorin, J. M. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.908238 · Cited by 12 · cited 1×
“Results of the initial search have also been reviewed previously (Grunze and Azorin 2014).”
BackgroundSelf-citationHigh-Dose Ziprasidone Monotherapy in Bipolar I Disorder Patients With Depressed or Mixed Episodes
Mech, A. W. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31816745de · Cited by 12 · cited 1×
“A case report by Mech (2008) reports good efficacy in three out of four treatment-refractory mixed patients, both for manic and depressive symptoms.”
BackgroundDepression symptom ratings in geriatric patients with bipolar mania
Sajatovic, M., Jurdi, R. A., Gildengers, A. G., Greenberg, R. L., TenHave, T. R., BRUCE, M. L., Mulsant, B. H., & Young, R. C. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2664 · Cited by 12 · cited 1×
“Mixed features appear frequent in geriatric patients with bipolar disorder (Sajatovic et al. 2011).”
BackgroundUse of asenapine in clinical practice for the management of bipolar mania
Young, A. H., Altamura, A. C., González-Pinto, A. M., Millet, B., & Wiedemann, K. (2013) · Journal of Psychopharmacology · doi:10.1177/1359786813482534 · Cited by 12 · cited 1×
“A synopsis of clinical cases is in line with a good efficacy and safety profile of asenapine (Young et al. 2013).”
ResultTohen, M. F., Mintz, J., & Bowden, C. L. (2016) · Bipolar Disorders · doi:10.1111/bdi.12383 · Cited by 12 · cited 2×
“…study of olanzapine versus lithium in recently manic or mixed patients (Tohen et al. 2005) utilising Multi-state Outcome Analysis of Treatments (MOAT) revealed that patients taking lithium spent significantly more time in mixed states than did patients taking olanzapine (Tohen et al. 2016).”
ResultSelf-citationSchaffer, C. B., Schaffer, L. C., NORDAHL, T. E., Stark, N. M., & Gohring, C. E. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000450 · Cited by 11 · cited 8×
“MST, mood stabiliser (lithium or valproate); TAU, treatment as usual.”
BackgroundInfluentialWoo, Y. S., Bahk, W., Jon, D., Chung, S., Lee, S., Ahn, Y. M., Pae, C., Cho, H. S., Kim, J., Hwang, T., et al. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02026.x · Cited by 9 · cited 2×
“A prospective open-label study from South Korea, examining adjunctive risperidone (plus mood stabiliser) in manic and mixed patients (n¼ 44) reported significant improvement of both manic and depressive symptoms in both subgroups over 24 weeks (Woo et al. 2010)”
BackgroundPae, C., Patkar, A. A., Gilmer, W. S., Holtzman, N. S., Thommi, S. B., & Ghaemi, S. N. (2012) · Pharmacopsychiatry · doi:10.1055/s-0031-1297984 · Cited by 9 · cited 1×
“The same study was also subject to an earlier report (Pae et al. 2012) that did not find any significant effects.”
ResultIntensive rTMS applications in difficult to treat psychiatric patients: some cases.
Zeeuws, D., Santermans, L., Baeken, C., & Vanderbruggen, N. (2010) · PubMed · Cited by 7
Tang, C., Yeh, C., Huang, Y., Wang, L., Chou, W., Chou, M., & Chen, C. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.505345 · Cited by 6 · cited 1×
“However, aripiprazole performed significantly better in manic than in depressive or mixed patients, and improvement of BPRS ratings in mixed patients was only marginal (Tang et al. 2010).”
BackgroundBiological aspects of rapid-cycling and mixed states
Grunze, H., & Walden, J. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019.015 · Cited by 5 · cited 1×
“Although already well characterised by Weygandt (1899), a medical assistant of Kraepelin, mixed states only recently experienced the attention that they deserve, given their high frequency and unfavourable prognosis (Grunze and Walden 2005).”
BackgroundSelf-citationPharmacological treatment outcomes in Latin American patients with bipolar I disorder
Bonetto, G. G., Nieto, I., Chapa, R., Adrianzén, C., Brnabic, A. J. M., Meyers, A. L., Granger, R. E., Dossenbach, M. R. K., Karagianis, J. L., & Ruíz, I. (2009) · Archivos de Neurociencias · Cited by 5
McIntyre, R. S., Hirschfeld, R. M. A., Alphs, L. D., Cohen, M., Macek, T. A., & Panagides, J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.12.016 · Cited by 4 · cited 1×
“Of the 960 patients analysed from the two acute studies (McIntyre et al. 2008; McIntyre et al. 2010a), 34%, 18% and 4.3% of patients, respectively, had 3 depressive features with mild (score 1 for MADRS items and 2 for PANSS item), moderate (score 2 MADRS, 3 PANSS) and severe (score 3 MADRS, 4…”
BackgroundInfluentialZimina, S. V., Kostyukova, E. G., & Mosolov, S. N. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611612134-38 · Cited by 3 · cited 1×
“A small open study in 20 bipolar II patients on agomelatine monotherapy did not find any differences in efficacy between retarded and agitated (anxious) depressions as a proxy of mixed depressive states (Zimina et al. 2016).”
BackgroundSelf-citationCombative HF-rTMS treatment, for a bipolar I patient, following unsuccessful ECT.
Zeeuws, D., Santermans, L., Baeken, C., & Vanderbruggen, N. (2010) · PubMed · Cited by 2
Vieta, E., Durgam, S., Lu, K., Laszlovszky, I., Saliu, I., & Earley, W. R. (2017) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(17)31660-7 · Cited by 2 · cited 1×
“The least squares mean difference for cariprazine versus placebo in YMRS total score change from baseline to week 3 was –4.0 (P¼ 0.0254) in the mixed subgroup (Vieta et al. 2017).”
BackgroundInfluentialSelf-citationEfficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
Bowden, C. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510360044034 · Cited by 1 · cited 4×
“reported on a post hoc analysis of a 3-week RCT (Bowden et al. 1994) that enrolled 179 adult patients with RDC criteria for acute mania.”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 33
- Akiskal HS., 1994, J Clin Psychiatry, 55, 46
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- Baillarger J., 1854, Folie à double forme
- 10.1001/jama.271.12.918 · doi:10.1001/jama.271.12.918 · Paper page
- Cipriani A, 2013, Cochrane Database Syst Rev, 10, CD003196
- Citrome L., 2014, Expert Opin Drug Saf, 13, 803
- Ernst CL, 2002, J Clin Psychiatry, 63, 42
- Falret JP., 1854, Bull Acad Natl Méd, 19, 382
- Garcia-Bonetto GM, 2009, Archivos De Neurosci, 14, 215
- Himmelhoch JM, 1986, Psychopharmacol Bull, 22, 613
- Kraepelin E., 1899, Ein Lehrbuch für Studierende und Ärzte
- Mazzarini L, 2017, J Affect Disord
- McIntyre RS, 2011, Prim Care Companion CNS Disord, 13, CC
- Mokhber N, 2008, Neuropsychiatr Dis Treat, 4, 227
- Mosolov SN, 2009, Zh Nevrol Psikhiatr Im S S Korsakova, 109, 47
- Mosolov SN, 2009, Zh Nevrol Psikhiatr Im S S Korsakova, 109, 36
- Mosolov SN, 1990, Zh Nevropatol Psikhiatr Im S S Korsakova, 90, 121
- Mosolov SN., 1991, Zh Nevropatol Psikhiatr Im S S Korsakova, 91, 78
- Palma M, 2016, Depress Res Treat, 2016, 8306071
- Pichot P., 2004, Bull Acad Natl Med, 188, 275
- Pigott K, 2016, Cochrane Database Syst Rev, 9, CD003384
- Sharma V, 1999, J Psychiatry Neurosci, 24, 40
- 10.3109/10401239909147073 · doi:10.3109/10401239909147073
- Spitzer RL, 1975, Research diagnostic criteria (RDC) for a selected group of functional disorders
- Strejilevich SA, 2011, Ann Clin Psychiatry, 23, 186
- Strömgren LS., 1988, Convuls Ther, 4, 306
- Vanelle JM, 1994, Convuls Ther, 10, 195
- Vieta E, 1995, Int J Neuropsychopharmacol, 10, 491
- Whittier MC, 1995, J Clin Psychiatry, 56, 590
- Wilhelm S, 2007, Eur Psychiatry, 22, S 262
- World Health Organization, 1992, Clinical descriptions and diagnostic guidelines
- Zeeuws D, 2010, Psychiatr Danub, 22, S135
- Zeeuws D, 2010, Psychiatr Danub, 22, S164
Cited by
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Self-citationMcAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278
Self-citationStahl, S. M., Laredo, S., & Morrissette, D. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320905752 · Cited by 223
Nuñez, N. A., Joseph, B., Pahwa, M., Kumar, R., Resendez, M. G., Prokop, L. J., Veldic, M., Seshadri, A., Biernacka, J. M., Frye, M. A., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.134 · Cited by 215
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s259338 · Cited by 147
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., & on behalf of the Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic
- Affiliations
- Klinikum am Weissenhof (DE)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Warneford Hospital (GB)
- The University of Texas at San Antonio Health Science Center (US)
- Aalborg University Hospital (DK)
- Hôpital Sainte-Marguerite (FR)
- University of British Columbia (CA)
- Department for Therapy of Mental Disorders, Moscow Research Institute of Psychiatry, Moscow, Russia;
- Ludwig-Maximilians-Universität München (DE)
- Medical University of Vienna (AT)
- Corresponding author
- Grunze, Heinz
- ORCID
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2017-11-03
- Volume
- 19
- Issue
- 1
- Pages
- 2-58
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2766127294
- Cited by
- 187
- References
- 335
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 16 · 2023: 19 · 2022: 24 · 2021: 28 · 2020: 30 · 2019: 25 · 2018: 10 · 2017: 1
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- HAL AMU (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10010)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar disorder, acute treatment, long-term maintenance therapy, atypical antipsychotics, olanzapine, quetiapine, ziprasidone, valproic acid, lithium, recurrence prevention, manic symptoms, depressive symptoms
- MeSH terms
- Biological Psychiatry, Bipolar Disorder, Electroconvulsive Therapy, Humans, Societies, Medical, Antipsychotic Agents, Practice Guidelines as Topic, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.